Virus and TSE Safety made simple

5/6 March 2024, Barcelona, Spain

Course No. 21024

header-image

Speakers

Michael Schiffer

Michael Schiffer

CSL Behring

Objectives

It is the aim of this course to enlighten this world between “dead and alive”.

The nature of viruses postulates significant differences to micro-organisms. This uniqueness poses particular challenges to the detection, inactivation and removal of viruses.

All these specifics will be discussed in detail at this education course – in an understandable manner.

Another threat poses TSE (Transmissible spongiform encephalopathy). Numerous studies have been conducted to understand the route of transmission and the causing agents better. Nevertheless, misunderstandings and rumours circulate and cumulate in the statement: “We need a TSE-certificate for our activated charcoal.”

This course will give you a scientifically sound introduction into the field of TSE and the impact on the pharmaceutical Industry.

Background

The current situation has shown us that the development and production of vaccines can also attract enormous public attention. This makes it all the more important, especially when it comes to approval and production under time pressure, that the quality standards of good manufacturing practice are observed.

Virus safety is one of the major concerns in the development and production of biopharmaceuticals and biologics. Huge efforts are undertaken to prevent viral contamination. A series of guidelines was dedicated to that topic exclusively.

For many people who are involved in the development and production of biopharmaceuticals and biologics the world of viruses is a “black box”.

Target Group

The Education Course is directed to responsible personnel involved in the development and production of biopharmaceuticals and biologics
  • Research & Development
  • Quality Assurance
  • Regulatory Affairs
  • Production
  • Engineering
  • Quality Control
It is also useful for service providers, such as contract research organisations and contract manufacturers.

Presentations / Certificate

The presentations for this event will be available for you to download and print before and after the event. Please note that no printed materials will be handed out on site and that there will not be any opportunity to print the presentations on site. After the event, you will automatically receive your certificate of participation.

Programme

Virus and TSE Safety made simple

Seminar Programme as PDF

Elemental (Basic) Virology
  • Physiology (if you can use such a word)
  • Replication cycles
  • Vectors
  • Resistance properties
Exogenous (Adventitious) and Endogenous Virus
  • Terminology
  • Viral safety approach
  • Effects of virus infection on host cell
  • Detection of exogenous / endogenous virus
Design and Documentation of Virus Validation Studies
  • Sources
  • Virus spike preparation
  • Cytotoxicity/interference
  • Infectivity assay or NAT assay
  • Down scaling of manufacturing step
Methods for Virus Inactivation and Virus Removal
  • Virus reduction by manufacturing process steps for protein purification
  • Virus reduction by dedicated virus reduction steps
  • Robustness of virus reduction methods
Virus Safety of Raw Materials
  • Qualification of the material and its supplier
  • Sourcing, testing and manufacture of raw materials
  • Virus clearance studies
  • Testing prior and at production of biotech product
Virus Safety Aspects of Advanced Therapy Medicinal Products (ATMPs)
  • Regulatory background/certification
  • Gene therapy medicinal products
  • Cell-based medicinal products
Pathogen Safety Risk Assessments
  •  What to consider and how to perform risk assessments regarding pathogen safety, incl. deviations and changes
  •  Introduction into Segregation Risk Analysis
  •  Case studies
Virus Safety: Regulatory Background
  • ICH Guidelines (ICH Q5A)
  • European Guidelines (EMEA)
  • European Pharmacopoeia
  • Risk assessment
  • Clinical trials in Europe
Transmissible Spongiform Encephalopathy (TSE) - Biology
  • The nature and transmission of TSE agents (prions)
  • Epidemiology
  • Methods for detecting TSE agents
  • Resistance/inactivation of prions, cleaning/disinfection
  • Prion reduction techniques
Transmissible Spongiform Encephalopathy (TSE) - Regulatory
  • EU Legislation (food, medicinal products, medicinal devices)
  • EMEA TSE note for guidance
  • EDQM TSE Certification Procedure
  • Regulations for blood and urine derived medicinal products
Interactive Workshops with Case Studies and Examples
During this workshops, the participants develop in small groups approaches to manufacture pathogen safe products, e.g. choosing testing strategies and calculating safety margins.

stop

This course is part of the GMP Certification Programme "ECA Certified Microbiological Laboratory Manager" Learn more

This training/webinar cannot be booked. Send us your inquiry by using the following contact form.

To find alternative dates for this training/webinar or similar events please see the complete list of all events.

For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.

* also payable by credit card
American Express Visa Mastercard

icon
Further dates on-site
Further dates on-site
Not available
icon
Further dates online
Further dates online
Not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023